The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis

Bibliographic Details
Main Author: Yamamoto, Eduardo S.
Publication Date: 2015
Other Authors: Campos, Bruno L S, Jesus, Jéssica A., Laurenti, Márcia D., Ribeiro, Susan P., Kallás, Esper G., Rafael-Fernandes, Mariana, Santos-Gomes, Gabriela, Silva, Marcelo S., Sessa, Deborah P., Lago, João H G, Levy, Débora, Passero, Luiz F D
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://doi.org/10.1371/journal.pone.0144946
Summary: PMID: 26674781 WOS:000366722700076
id RCAP_2ef757ebdd75e6202f0d3c5440e6159f
oai_identifier_str oai:run.unl.pt:10362/36594
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasisAgricultural and Biological Sciences(all)Biochemistry, Genetics and Molecular Biology(all)Medicine(all)SDG 3 - Good Health and Well-beingPMID: 26674781 WOS:000366722700076Among neglected tropical diseases, leishmaniasis is one of the most important ones, affecting more than 12 million people worldwide. The available treatments are not well tolerated, and present diverse side effects, justifying the search for new therapeutic compounds. In the present study, the activity of ursolic acid (UA) and oleanolic acid (OA) were assayed in experimental cutaneous leishmaniasis (in vitro and in vivo). Promastigote forms of L. amazonensis were incubated with OA and UA for 24h, and effective concentration 50% (EC50) was estimated. Ultraestructural alterations in Leishmania amazonensis promastigotes after UA treatment were evaluated by transmission electron microscopy, and the possible mode of action was assayed through Annexin V and propidium iodide staining, caspase 3/7 activity, DNA fragmentation and transmembrane mitochondrial potential. The UA potential was evaluated in intracellular amastigotes, and its therapeutic potential was evaluated in L. amazonensis infected BALB/c mice. UA eliminated L. amazonensis promastigotes with an EC50 of 6.4 μg/mL, comparable with miltefosine, while OA presented only a marginal effect on promastigote forms at 100 μg/mL. The possible mechanism by which promastigotes were eliminated by UA was programmed cell death, independent of caspase 3/7, but it was highly dependent on mitochondria activity. UA was not toxic for peritoneal macrophages from BALB/c mice, and it was able to eliminate intracellular amastigotes, associated with nitricoxide (NO) production. OA did not eliminate amastigotes nor trigger NO. L. amazonensis infected BALB/c mice submitted to UA treatment presented lesser lesion size and parasitism compared to control. This study showed, for the first time, that UA eliminate promastigote forms through a mechanism associated with programed cell death, and importantly, was effective in vivo. Therefore, UA can be considered an interesting candidate for future tests as a prototype drug for the treatment of cutaneous leishmaniasis.Global Health and Tropical Medicine (GHTM)Instituto de Higiene e Medicina Tropical (IHMT)Vector borne diseases and pathogens (VBD)RUNYamamoto, Eduardo S.Campos, Bruno L SJesus, Jéssica A.Laurenti, Márcia D.Ribeiro, Susan P.Kallás, Esper G.Rafael-Fernandes, MarianaSantos-Gomes, GabrielaSilva, Marcelo S.Sessa, Deborah P.Lago, João H GLevy, DéboraPassero, Luiz F D2018-05-11T22:03:10Z2015-12-012015-12-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.1371/journal.pone.0144946eng1932-6203PURE: 1733426http://www.scopus.com/inward/record.url?scp=84956613295&partnerID=8YFLogxKhttps://doi.org/10.1371/journal.pone.0144946info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-05-22T17:32:36Zoai:run.unl.pt:10362/36594Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T17:03:34.544681Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis
title The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis
spellingShingle The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis
Yamamoto, Eduardo S.
Agricultural and Biological Sciences(all)
Biochemistry, Genetics and Molecular Biology(all)
Medicine(all)
SDG 3 - Good Health and Well-being
title_short The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis
title_full The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis
title_fullStr The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis
title_full_unstemmed The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis
title_sort The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis
author Yamamoto, Eduardo S.
author_facet Yamamoto, Eduardo S.
Campos, Bruno L S
Jesus, Jéssica A.
Laurenti, Márcia D.
Ribeiro, Susan P.
Kallás, Esper G.
Rafael-Fernandes, Mariana
Santos-Gomes, Gabriela
Silva, Marcelo S.
Sessa, Deborah P.
Lago, João H G
Levy, Débora
Passero, Luiz F D
author_role author
author2 Campos, Bruno L S
Jesus, Jéssica A.
Laurenti, Márcia D.
Ribeiro, Susan P.
Kallás, Esper G.
Rafael-Fernandes, Mariana
Santos-Gomes, Gabriela
Silva, Marcelo S.
Sessa, Deborah P.
Lago, João H G
Levy, Débora
Passero, Luiz F D
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Global Health and Tropical Medicine (GHTM)
Instituto de Higiene e Medicina Tropical (IHMT)
Vector borne diseases and pathogens (VBD)
RUN
dc.contributor.author.fl_str_mv Yamamoto, Eduardo S.
Campos, Bruno L S
Jesus, Jéssica A.
Laurenti, Márcia D.
Ribeiro, Susan P.
Kallás, Esper G.
Rafael-Fernandes, Mariana
Santos-Gomes, Gabriela
Silva, Marcelo S.
Sessa, Deborah P.
Lago, João H G
Levy, Débora
Passero, Luiz F D
dc.subject.por.fl_str_mv Agricultural and Biological Sciences(all)
Biochemistry, Genetics and Molecular Biology(all)
Medicine(all)
SDG 3 - Good Health and Well-being
topic Agricultural and Biological Sciences(all)
Biochemistry, Genetics and Molecular Biology(all)
Medicine(all)
SDG 3 - Good Health and Well-being
description PMID: 26674781 WOS:000366722700076
publishDate 2015
dc.date.none.fl_str_mv 2015-12-01
2015-12-01T00:00:00Z
2018-05-11T22:03:10Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.1371/journal.pone.0144946
url https://doi.org/10.1371/journal.pone.0144946
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1932-6203
PURE: 1733426
http://www.scopus.com/inward/record.url?scp=84956613295&partnerID=8YFLogxK
https://doi.org/10.1371/journal.pone.0144946
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833596404371554304